The US Food and Drug Administration is considering new rules for authorization for a Covid 19 vaccine , according to three sources familiar with the situation -- and calculations show these rules would push an authorization beyond Election Day . 
That would dash the hopes of President Donald Trump , who has said repeatedly the vaccine could be ready by November 3 . 
The sources described two different scenarios that the FDA is assessing before a pharmacy company can be given an emergency use authorization for its vaccine . 
That source said the FDA is expected to tell vaccine makers that they need to wait two months after giving all their study participants their second doses of the vaccine until they can apply for an EUA . 
Pfizer and Moderna , the two companies that began Phase 3 clinical trials for coronavirus vaccines in the US in July , have given second doses to fewer than half of their participants . 
" They ( the FDA ) are strongly considering this move . 
They have not said the ' thou shalt , ' but they are giving signals that this is important to them and they are moving in this direction , " the source said . 
Read the full story : 
